* NHS PREDICT is available online at breast.predict.nhs.uk. Genomic assays, if used, can also assess risk of recurrence.
ΒΆ Clodronate and ibandronate cannot be prescribed in the United States. Ibandronate does not have direct evidence to support a disease-free survival benefit and is less preferred than zoledronic acid or clodronate.